drugset / Trial / NCT01708915

Nonivamide/Nicoboxil Ointment in Acute Low Back Pain

NCT01708915 ↗

Phase 3 Completed 805 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to assess the efficacy and tolerability of Nicoboxil/Nonivamide ointment in comparison to Nicoboxil, Nonivamide, and placebo ointments for the treatment of acute low back pain.

Timeline

Start
2012-10
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator nicoboxil Small molecule 2.5 % Topical
Comparator nonivamide Small molecule 0.4 % Topical

Indications

No indication recorded.